Skip to content
★ Sign in to follow
MI

MDV IX LP

Related company / holding
Coupa Software IncAdamas Pharmaceuticals Inc
Total declarations
21
Companies
2
▲ Purchases (8 ops.)
€3.6M
▼ Sales (12 ops.)
€72.1M

Latest filing published 14 Jul 2017 for Coupa Software Inc, €45.5M.

Filing timeline

BuySale
MDV IX LP

Insider track record

Disclosed buys
8
Disclosed sells
12
Signal history

Closed purchases

Market purchases
8

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

MDV IX LP: trading record in brief

MDV IX LP is a declared insider at 2 companies; the most frequent names are Adamas Pharmaceuticals Inc and Coupa Software Inc. Between 17 March 2015 and 12 July 2017, the trades on record add up to 21 filings.

Market trades split into 8 purchases (€3.6M) and 12 sales (€72.1M). Taken together, the sales exceed the purchases by €68.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2017 to date brings no purchases and 2 sales.

Half of the purchases are above €443k and half below. Of 8 purchases, 8 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 14 July 2017: an open-market sale of €45.5M, in Coupa Software Inc. The most recent open-market purchase was published on 16 September 2016, 3,706 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to MDV IX LP

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total
  • ▼
    Related company / holdingExecutivesCoupa Software Inc
    52M USD30SEC
    1,662,000 shares@ US$31.2567.0% of flowCommon StockSEC:0001209191-17-045231:0
  • ▼
    Related company / holdingExecutivesCoupa Software Inc
    24M USD26SEC
    1,000,000 shares@ US$24.0533.0% of flowCommon StockSEC:0001209191-17-027727:0
  • ●
    Related company / holdingExecutivesCoupa Software Inc
    0SEC
    6,648,700 sharesCommon StockSEC:0001209191-16-145895:0
  • ▲
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    895,787 USD25SEC
    54,537 shares@ US$16.425322.0% of flowCommon StockSEC:0001209191-16-141889:0
    Canonical exit: 13 Dec 2016 (T+90)
  • ▲
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    3,300 USD23SEC
    200 shares@ US$16.500.1% of flowCommon StockSEC:0001209191-16-141889:1
    Canonical exit: 14 Dec 2016 (T+90)
  • ▲
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    138,497 USD23SEC
    8,240 shares@ US$16.80793.4% of flowCommon StockSEC:0001209191-16-141889:2
    Canonical exit: 15 Dec 2016 (T+90)
  • ▲
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    349,735 USD24SEC
    22,342 shares@ US$15.65378.6% of flowCommon StockSEC:0001209191-16-141471:0
    Canonical exit: 11 Dec 2016 (T+90)
  • ▲
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    964,995 USD25SEC
    62,034 shares@ US$15.555923.8% of flowCommon StockSEC:0001209191-16-141471:1
    Canonical exit: 12 Dec 2016 (T+90)
  • ▲
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    954,065 USD23SEC
    60,846 shares@ US$15.6823.5% of flowCommon StockSEC:0001209191-16-140846:0
    Canonical exit: 6 Dec 2016 (T+90)
  • ▲
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    644,921 USD19SEC
    43,719 shares@ US$14.751515.9% of flowCommon StockSEC:0001209191-16-140473:0
    Canonical exit: 1 Dec 2016 (T+90)
  • ▲
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    107,980 USD19SEC
    7,200 shares@ US$14.99722.7% of flowCommon StockSEC:0001209191-16-140473:1
    Canonical exit: 5 Dec 2016 (T+90)
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    238,308 USD0SEC
    8,657 shares@ US$27.5278Common StockSEC:0001209191-15-060844:0
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    708,931 USD0SEC
    25,737 shares@ US$27.5452Common StockSEC:0001209191-15-060272:0
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    85,408 USD0SEC
    3,100 shares@ US$27.551Common StockSEC:0001209191-15-060272:1
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    436,251 USD0SEC
    15,842 shares@ US$27.5376Common StockSEC:0001209191-15-055487:0
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    134,821 USD0SEC
    7,483 shares@ US$18.017Common StockSEC:0001209191-15-048533:0
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    2M USD0SEC
    112,073 shares@ US$18.02Common StockSEC:0001209191-15-048533:1
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    29,640 USD0SEC
    1,643 shares@ US$18.04Common StockSEC:0001209191-15-045100:0
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    688,056 USD0SEC
    37,078 shares@ US$18.557Common StockSEC:0001209191-15-034141:0
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    81,414 USD0SEC
    4,523 shares@ US$18.00Common StockSEC:0001209191-15-028056:0
  • ▼
    Related company / holdingExecutivesAdamas Pharmaceuticals Inc
    129,893 USD0SEC
    7,200 shares@ US$18.0407Common StockSEC:0001209191-15-028056:1

21 of 21 declarations